It is reported，Tzuhiki ’s injection of Salviasis polyphenolic acid is prepared to submit an IND application to the US Food and Drug Administration (FDA)，Piercing Heart Lotus Drip Pills、Shuilin Jia has launched clinical research on the FDA respectively，The current work is progressing smoothly。

    Tzuhiki 2013 Half -annual Report once pointed out，During the period, the company further promoted the clinical trial of compound Dantan Di Pill My stake betting appin stake sports betting appthe III phase III in the United States，Selected Shuilin Jia、The two products of wearing the heart lotus latency pill have completed the FDA-inde-submitting work，At the same time, wearing heart lotus latenat drip pills and Qishen Yishi drop pills obtained Canadian plant medicine batch，The internationalization process of Chinese medicine further moves further。

    The above three Taskina for the newly entered the FDA certification team，All are Tasse's second- and third -tier products，Among them, spiny polyphenolic acid for injection is expected to exceed 100 million yuan in 2013，Shuilin Jia、Wearing Lotus Large stake betting appStake Sports BettingPills Pills in 2013 will be expected to exceed 30%、70%。